These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23953689)

  • 1. Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.
    St John SE; Jensen KC; Kang S; Chen Y; Calamini B; Mesecar AD; Lipton MA
    Bioorg Med Chem; 2013 Oct; 21(19):6022-37. PubMed ID: 23953689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of quinone reductase 2 in complex with resveratrol.
    Buryanovskyy L; Fu Y; Boyd M; Ma Y; Hsieh TC; Wu JM; Zhang Z
    Biochemistry; 2004 Sep; 43(36):11417-26. PubMed ID: 15350128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.
    Sun B; Hoshino J; Jermihov K; Marler L; Pezzuto JM; Mesecar AD; Cushman M
    Bioorg Med Chem; 2010 Jul; 18(14):5352-66. PubMed ID: 20558073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Old and new inhibitors of quinone reductase 2.
    Ferry G; Hecht S; Berger S; Moulharat N; Coge F; Guillaumet G; Leclerc V; Yous S; Delagrange P; Boutin JA
    Chem Biol Interact; 2010 Jul; 186(2):103-9. PubMed ID: 20399199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray structural studies of quinone reductase 2 nanomolar range inhibitors.
    Pegan SD; Sturdy M; Ferry G; Delagrange P; Boutin JA; Mesecar AD
    Protein Sci; 2011 Jul; 20(7):1182-95. PubMed ID: 21538647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2.
    Calamini B; Santarsiero BD; Boutin JA; Mesecar AD
    Biochem J; 2008 Jul; 413(1):81-91. PubMed ID: 18254726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2.
    Reddy PV; Jensen KC; Mesecar AD; Fanwick PE; Cushman M
    J Med Chem; 2012 Jan; 55(1):367-77. PubMed ID: 22206487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic mechanisms facilitated by resveratrol and its metabolites.
    Calamini B; Ratia K; Malkowski MG; Cuendet M; Pezzuto JM; Santarsiero BD; Mesecar AD
    Biochem J; 2010 Jul; 429(2):273-82. PubMed ID: 20450491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the redox cycle of human quinone reductase 2.
    Reybier K; Perio P; Ferry G; Bouajila J; Delagrange P; Boutin JA; Nepveu F
    Free Radic Res; 2011 Oct; 45(10):1184-95. PubMed ID: 21762045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three Australian Lepidosperma Labill. Species as sources of prenylated and oxyprenylated derivatives of piceatannol, resveratrol and pinosylvin: Melatoninergic binding and inhibition of quinone reductase 2.
    Hamid K; Tran VH; Duke RK; Duke CC
    Phytochemistry; 2022 Nov; 203():113396. PubMed ID: 35998831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of open-access databases to determine functional connectivity between resveratrol-binding protein QR2 and colorectal carcinoma.
    Doonan BB; Schaafsma E; Pinto JT; Wu JM; Hsieh TC
    In Vitro Cell Dev Biol Anim; 2017 Aug; 53(7):575-578. PubMed ID: 28646291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based inhibition of quinone reductase 2 (NQO2): selectivity for NQO2 over NQO1 and structural basis for flavoprotein inhibition.
    Dufour M; Yan C; Siegel D; Colucci MA; Jenner M; Oldham NJ; Gomez J; Reigan P; Li Y; De Matteis CI; Ross D; Moody CJ
    Chembiochem; 2011 May; 12(8):1203-8. PubMed ID: 21506232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities.
    Maiti A; Reddy PV; Sturdy M; Marler L; Pegan SD; Mesecar AD; Pezzuto JM; Cushman M
    J Med Chem; 2009 Apr; 52(7):1873-84. PubMed ID: 19265439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB.
    Kang SS; Cuendet M; Endringer DC; Croy VL; Pezzuto JM; Lipton MA
    Bioorg Med Chem; 2009 Feb; 17(3):1044-54. PubMed ID: 18487053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of mammalian cytosolic quinone reductases.
    Foster CE; Bianchet MA; Talalay P; Faig M; Amzel LM
    Free Radic Biol Med; 2000 Aug; 29(3-4):241-5. PubMed ID: 11035252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of quinone reductase 2 by resveratrol in cultured vascular smooth muscle cells.
    Cai JB; Zhang ZH; Xu DJ; Qian ZY; Wang ZR; Huang YZ; Zou JG; Cao KJ
    Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1419-25. PubMed ID: 18671725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a potent melatonin-based inhibitor of quinone reductase-2 with neuroprotective and neurogenic properties.
    Herrera-Arozamena C; Estrada-Valencia M; García-Díez G; Pérez C; León R; Infantes L; Morales-García JA; Pérez-Castillo A; Del Sastre E; López MG; Rodríguez-Franco MI
    Eur J Med Chem; 2024 Nov; 277():116763. PubMed ID: 39146834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of quinone reductase 2 function selectively facilitates learning behaviors.
    Benoit CE; Bastianetto S; Brouillette J; Tse Y; Boutin JA; Delagrange P; Wong T; Sarret P; Quirion R
    J Neurosci; 2010 Sep; 30(38):12690-700. PubMed ID: 20861374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines.
    Kwiek JJ; Haystead TA; Rudolph J
    Biochemistry; 2004 Apr; 43(15):4538-47. PubMed ID: 15078100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer's disease phenotype in mice.
    Gould NL; Scherer GR; Carvalho S; Shurrush K; Kayyal H; Edry E; Elkobi A; David O; Foqara M; Thakar D; Pavesi T; Sharma V; Walker M; Maitland M; Dym O; Albeck S; Peleg Y; Germain N; Babaev I; Sharir H; Lalzar M; Shklyar B; Hazut N; Khamaisy M; Lévesque M; Lajoie G; Avoli M; Amitai G; Lefker B; Subramanyam C; Shilton B; Barr H; Rosenblum K
    J Clin Invest; 2023 Oct; 133(19):. PubMed ID: 37561584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.